AAAAAA

   
Results: 1-16 |
Results: 16
Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study
Authors: Wildemore, JK Schuchter, L Mick, R Synnestvedt, M Elenitsas, R Bedrosian, I Czerniecki, BJ Guerry, D Lessin, SR Elder, DE Bucky, LP
Citation: Jk. Wildemore et al., Locally recurrent malignant melanoma characteristics and outcomes: A single-institution study, ANN PL SURG, 46(5), 2001, pp. 488-494
Interleukin-4 up-regulates mouse mammary tumor virus expression yet is notrequired for in vivo virus spread
Authors: Czarneski, J Meyers, J Peng, T Agraham, V Mick, R Ross, SR
Citation: J. Czarneski et al., Interleukin-4 up-regulates mouse mammary tumor virus expression yet is notrequired for in vivo virus spread, J VIROLOGY, 75(23), 2001, pp. 11886-11890
Pediatric Crohn's disease: Risk factors for postoperative recurrence
Authors: Baldassano, RN Han, PD Jeshion, WC Berlin, JA Piccoli, DA Lautenbach, E Mick, R Lichtenstein, GR
Citation: Rn. Baldassano et al., Pediatric Crohn's disease: Risk factors for postoperative recurrence, AM J GASTRO, 96(7), 2001, pp. 2169-2176
Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation
Authors: Mathias, C Mick, R Grupp, S Duffy, K Harris, F Laport, G Stadtmauer, E Luger, S Schuster, S Wasik, MA Porter, DL
Citation: C. Mathias et al., Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation, J HEMATH ST, 9(3), 2000, pp. 393-400
Incidence of sentinel node metastasis in patients with thin primary melanoma (<= 1 mm) with vertical growth phase
Authors: Bedrosian, I Faries, MB Guerry, D Elenitsas, R Schuchter, L Mick, R Spitz, FR Bucky, LP Alavi, A Elder, DE Fraker, DL Czerniecki, BJ
Citation: I. Bedrosian et al., Incidence of sentinel node metastasis in patients with thin primary melanoma (<= 1 mm) with vertical growth phase, ANN SURG O, 7(4), 2000, pp. 262-267
Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint
Authors: Mick, R Crowley, JJ Carroll, RJ
Citation: R. Mick et al., Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint, CONTR CL TR, 21(4), 2000, pp. 343-359
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS
Authors: Cohen-Jonathan, E Muschel, RJ McKenna, WG Evans, SM Cerniglia, G Mick, R Kusewitt, D Sebti, SM Hamilton, AD Oliff, A Kohl, N Gibbs, JB Bernhard, EJ
Citation: E. Cohen-jonathan et al., Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS, RADIAT RES, 154(2), 2000, pp. 125-132
p16(INK4a) expression begins early in human colon neoplasia and correlatesinversely with markers of cell proliferation
Authors: Dai, CY Furth, EE Mick, R Koh, J Takayama, T Niitsu, Y Enders, GH
Citation: Cy. Dai et al., p16(INK4a) expression begins early in human colon neoplasia and correlatesinversely with markers of cell proliferation, GASTROENTY, 119(4), 2000, pp. 929-942
Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors
Authors: Bedrosian, I Reynolds, C Mick, R Callans, LS Grant, CS Donohue, JH Farley, DR Heller, R Conant, E Orel, SG Lawton, T Fraker, DL Czerniecki, BJ
Citation: I. Bedrosian et al., Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors, CANCER, 88(11), 2000, pp. 2540-2545
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
Authors: Porter, DL Collins, RH Hardy, C Kernan, NA Drobyski, WR Giralt, S Flowers, MED Casper, J Leahey, A Parker, P Mick, R Bate-Boyle, B King, R Antin, JH
Citation: Dl. Porter et al., Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions, BLOOD, 95(4), 2000, pp. 1214-1221
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination
Authors: Stadtmauer, EA Tsai, DE Sickles, CJ Mick, R Luger, SM Porter, DL Mangan, PA Schuchter, LM Schuster, SJ Loh, EY Magee, DA Sachs, RA Wall, ME Moore, J Buzby, GP Zaleta, E Kamoun, M Silberstein, LE
Citation: Ea. Stadtmauer et al., Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination, MED ONCOL, 16(4), 1999, pp. 279-288
Combined therapy with chemotherapeutic agents and herpes simplex virus type IICP34.5 mutant (HSV-1716) in human non-small cell lung cancer
Authors: Toyoizumi, T Mick, R Abbas, AE Kang, EH Kaiser, LR Molnar-Kimber, KL
Citation: T. Toyoizumi et al., Combined therapy with chemotherapeutic agents and herpes simplex virus type IICP34.5 mutant (HSV-1716) in human non-small cell lung cancer, HUM GENE TH, 10(18), 1999, pp. 3013-3029
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
Authors: Moore, HCF Mick, R Solin, LJ Sickles, C Mangan, PA Luger, SM Fox, KR Schuchter, LM Loh, E Porter, DL Schuster, S Buzby, GP Glatstein, E Silberstein, LE Stadtmauer, EA
Citation: Hcf. Moore et al., Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy, ANN ONCOL, 10(8), 1999, pp. 929-936
Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma
Authors: Zimmerman, TM Michelson, GC Mick, R Grinblatt, DL Williams, SF
Citation: Tm. Zimmerman et al., Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma, J CLIN APH, 14(1), 1999, pp. 31-34
Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
Authors: Reynolds, C Mick, R Donohue, JH Grant, CS Farley, DR Callans, LS Orel, SG Keeney, GL Lawton, TJ Czerniecki, BJ
Citation: C. Reynolds et al., Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?, J CL ONCOL, 17(6), 1999, pp. 1720-1726
Tc-99m-human serum albumin: An effective radiotracer for identifying sentinel lymph nodes in melanoma
Authors: Bedrosian, I Scheff, AM Mick, R Callans, LS Bucky, LP Spitz, FR Helsabeck, C Elder, DE Alavi, A Fraker, DF Czerniecki, BJ
Citation: I. Bedrosian et al., Tc-99m-human serum albumin: An effective radiotracer for identifying sentinel lymph nodes in melanoma, J NUCL MED, 40(7), 1999, pp. 1143-1148
Risultati: 1-16 |